Bone scans overstage prostate cancer at initial staging compared with PSMA PET: Study

Bone scans have been found to overstage prostate cancer at initial staging compared to prostate-specific membrane antigen (PSMA) PET, according to new research published in the November issue of the Journal of Nuclear Medicine. The significant false-positive rate of metastases on bone scans means that definitive therapy for local disease may have been withheld from patients inappropriately.